The 36-month beta value for OCEA is at 1.56. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for OCEA is 9.14M, and currently, shorts hold a 2.37% of that float. The average trading volume for OCEA on July 29, 2024 was 223.83K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
OCEA) stock’s latest price update
Ocean Biomedical Inc. (NASDAQ: OCEA) has experienced a rise in its stock price by 14.29 compared to its previous closing price of 1.12. However, the company has seen a gain of 16.36% in its stock price over the last five trading days. globenewswire.com reported 2024-06-05 that Providence, RI, June 05, 2024 (GLOBE NEWSWIRE) — Ocean Biomedical, Inc. (NASDAQ: OCEA ), a biopharma company working to accelerate the development of compelling discoveries from top research scientists, today congratulates its JV partner Virion Therapeutics, LLC, a clinical-stage biotechnology company developing novel T cell-based immunotherapies, on its late breaker presentation highlighting the first-ever human immunogenicity data from its novel checkpoint modifier immunotherapy for HBV functional cure (VRON-0200), at the EASL 2024 Congress (The European Association for the Study of the Liver), taking place in Milan, Italy from June 5 – 8.
OCEA’s Market Performance
Ocean Biomedical Inc. (OCEA) has experienced a 16.36% rise in stock performance for the past week, with a -6.57% drop in the past month, and a 1.99% rise in the past quarter. The volatility ratio for the week is 9.21%, and the volatility levels for the past 30 days are at 9.15% for OCEA. The simple moving average for the past 20 days is 10.92% for OCEA’s stock, with a -18.88% simple moving average for the past 200 days.
OCEA Trading at -6.01% from the 50-Day Moving Average
After a stumble in the market that brought OCEA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -83.57% of loss for the given period.
Volatility was left at 9.15%, however, over the last 30 days, the volatility rate increased by 9.21%, as shares sank -7.25% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -17.95% lower at present.
During the last 5 trading sessions, OCEA rose by +16.36%, which changed the moving average for the period of 200-days by -45.53% in comparison to the 20-day moving average, which settled at $1.1490. In addition, Ocean Biomedical Inc. saw 93.94% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for OCEA
The total capital return value is set at 0.35. Equity return is now at value -678.22, with -176.47 for asset returns.
Based on Ocean Biomedical Inc. (OCEA), the company’s capital structure generated -0.19 points at debt to capital in total, while cash flow to debt ratio is standing at -0.71. The debt to equity ratio resting at -0.16. The interest coverage ratio of the stock is -4.22.
Currently, EBITDA for the company is -0.96 million with net debt to EBITDA at -0.47. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.03.
Conclusion
In conclusion, Ocean Biomedical Inc. (OCEA) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
